Robert E. Molokie

Haloperidol or amitriptyline for chronic neuropathic pain in adults with sickle cell disease: A systematic review

Abstract Chronic pain affects more than half of adults with sickle cell disease (SCD), and a clinically meaningful subgroup—reported in 32% to 70% of cohorts depending on the screening tool—exhibits a neuropathic component that is poorly responsive to opioids and other standard a...